Thirty-seven breast/ovarian or breast-only cancer families selected on a re
gional basis have been analyzed for mutations at BRCA1. By combining direct
sequence analysis and protein truncation test, mutations Were detected in
14 families (38%). We found seven different mutations, two of which have no
t been described before. Mutations at BRCA1 were present in 60% of breast/o
varian and 32% of breast-only cancer families. Mutations were frequent in f
amilies with at least one breast cancer case before age 40 (44%) and/or one
bilateral breast cancer case (54%). Two mutations, namely 3600del11 and G1
710X, are frequent in the population native from northeastern France. Orien
ted BRCA1 analysis should facilitate carrier detection in breast and/or ova
rian cancer families stemming from this French area.